Xavier Carbonell Estrany-rekin lankidetzan egindako argitalpenak (3)

2023

  1. Prioritising respiratory syncytial virus prevention in low-income and middle-income countries

    The Lancet Global Health

2020

  1. Expert consensus on palivizumab use for respiratory syncytial virus in developed countries

    Paediatric Respiratory Reviews, Vol. 33, pp. 35-44

2018

  1. Interaction between healthcare professionals and parents is a key determinant of parental distress during childhood hospitalisation for respiratory syncytial virus infection (European RSV Outcomes Study [EROS])

    Acta Paediatrica, International Journal of Paediatrics, Vol. 107, Núm. 5, pp. 854-860